http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-081566-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9cc21c102a2aa9597ba6a7a2ea8a3cd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166 |
| filingDate | 2011-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-081566-A1 |
| titleOfInvention | METHODS TO TREAT PLATINUM-RESISTANT OVARIO CANCER WITH 4-IODO-3-NITROBENZAMIDE IN COMBINATION WITH AN ANTIMETABOLIT AND A PLATINUM COMPOSITE |
| abstract | Method for treating recurrent platinum resistant ovarian cancer in a patient, comprising administering to the patient an effective amount of 4-iodo-3-nitrobenzamide or a pharmaceutically acceptable metabolite or salt thereof; gemcitabine; and carboplatin. Claim 16: A kit for the treatment of recurrent ovarian cancer platinum in a patient, comprising (i) 4-iodo-3-nitrobenzamide, one of its metabolites, or one of its pharmaceutically acceptable salts; (ii) gemcitabine; and (iii) carboplatin. |
| priorityDate | 2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.